<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC139432/" ref="ordinalpos=1849&amp;ncbi_uid=352469&amp;link_uid=PMC139432" image-link="/pmc/articles/PMC139432/figure/F1/" class="imagepopup">Figure 1.  From: Transforming growth factor-? and breast cancer: Transforming growth factor-?/SMAD <span class="highlight" style="background-color:">signaling</span> defects and cancer. </a></div><br /><div class="p4l_captionBody">This model schematically illustrates the various molecular mechanisms that can contribute to negative regulation of SMAD signaling and thereby to a loss of transforming growth factor (TGF)β-induced growth inhibition. Inactivating mutations or loss of expression of components of the TGFβ/SMAD signaling pathway are not depicted here but may also be important. For details, see text.</div></div>